Differential effect of obesity on cervical neoplastic progression and human papillomavirus persistence: A retrospective cohort study
Cancer Plus · 18.11.2026 · 026360058
DOI: 10.36922/cp026360058 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Cancer Plus, online erschienen am 18.11.2026. Verfasst von Cem Yagmur Ozdemir und 3 weiteren Autor:innen.
Abstract (Originalsprache)
The role of obesity in human papillomavirus (HPV) persistence and the development of cervical neoplasia remains incompletely understood. This study evaluates the independent effects of obesity, smoking, and age on high-risk HPV persistence and the development of high-grade cervical lesions (cervical intraepithelial neoplasia [CIN]2+), and assesses whether obesity improves prediction of CIN2+. This retrospective cohort study included 445 women who underwent high-risk HPV testing between December 2023 and December 2025. HPV persistence was defined as detection of the same HPV genotype in at least two consecutive tests performed ≥ 12 months apart. Body mass index was categorized as non-obese (
Zitieren
APA
Ozdemir, C. Y., Cicekli, N., Doğu, C., & Arioz, D. T. (2026). Differential effect of obesity on cervical neoplastic progression and human papillomavirus persistence: A retrospective cohort study. Cancer Plus, 0(0), 026360058. https://doi.org/10.36922/cp026360058
Vancouver
Ozdemir CY, Cicekli N, Doğu C, Arioz DT. Differential effect of obesity on cervical neoplastic progression and human papillomavirus persistence: A retrospective cohort study. Cancer Plus. 2026;0(0):026360058. doi:10.36922/cp026360058
BibTeX
@article{Ozdemir2026,
author = {Ozdemir, Cem Yagmur and Cicekli, Nayif and Doğu, Cevdet and Arioz, Dagistan Tolga},
title = {Differential effect of obesity on cervical neoplastic progression and human papillomavirus persistence: A retrospective cohort study},
journal = {Cancer Plus},
year = {2026},
volume = {0},
number = {0},
pages = {026360058},
doi = {10.36922/cp026360058}
}
EUVIMED